GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » E10

Coloplast AS (OCSE:COLO B) E10 : kr20.47 (As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Coloplast AS's adjusted earnings per share data for the three months ended in Mar. 2025 was kr4.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr20.47 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Coloplast AS's average E10 Growth Rate was 2.60% per year. During the past 3 years, the average E10 Growth Rate was 9.20% per year. During the past 5 years, the average E10 Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Coloplast AS was 13.30% per year. The lowest was 9.20% per year. And the median was 11.20% per year.

As of today (2025-07-15), Coloplast AS's current stock price is kr601.40. Coloplast AS's E10 for the quarter that ended in Mar. 2025 was kr20.47. Coloplast AS's Shiller PE Ratio of today is 29.38.

During the past 13 years, the highest Shiller PE Ratio of Coloplast AS was 84.59. The lowest was 29.32. And the median was 54.07.


Coloplast AS E10 Historical Data

The historical data trend for Coloplast AS's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS E10 Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.92 15.58 18.22 19.12 20.28

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.96 20.10 20.28 20.30 20.47

Competitive Comparison of Coloplast AS's E10

For the Medical Instruments & Supplies subindustry, Coloplast AS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Shiller PE Ratio falls into.


;
;

Coloplast AS E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast AS's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=4.05/120.2000*120.2000
=4.050

Current CPI (Mar. 2025) = 120.2000.

Coloplast AS Quarterly Data

per share eps CPI Adj_EPS
201506 3.320 100.300 3.979
201509 -6.680 100.200 -8.013
201512 3.870 99.800 4.661
201603 4.310 100.200 5.170
201606 4.600 100.600 5.496
201609 2.000 100.200 2.399
201612 4.460 100.300 5.345
201703 4.380 101.200 5.202
201706 4.290 101.200 5.095
201709 4.740 101.800 5.597
201712 4.420 101.300 5.245
201803 4.320 101.700 5.106
201806 4.470 102.300 5.252
201809 4.890 102.400 5.740
201812 4.660 102.100 5.486
201903 4.780 102.900 5.584
201906 5.020 102.900 5.864
201909 3.720 102.900 4.345
201912 5.120 102.900 5.981
202003 5.000 103.300 5.818
202006 4.670 103.200 5.439
202009 4.880 103.500 5.667
202012 5.330 103.400 6.196
202103 5.300 104.300 6.108
202106 5.880 105.000 6.731
202109 6.120 105.800 6.953
202112 5.660 106.600 6.382
202203 4.600 109.900 5.031
202206 6.060 113.600 6.412
202209 5.790 116.400 5.979
202212 5.310 115.900 5.507
202303 5.440 117.300 5.574
202306 5.980 116.400 6.175
202309 5.470 117.400 5.600
202312 5.390 116.700 5.552
202403 5.570 118.400 5.655
202406 5.660 118.500 5.741
202409 5.840 118.900 5.904
202412 4.630 118.900 4.681
202503 4.050 120.200 4.050

Add all the adjusted EPS together and divide 10 will get our e10.


Coloplast AS  (OCSE:COLO B) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Coloplast AS's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=601.40/20.47
=29.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Coloplast AS was 84.59. The lowest was 29.32. And the median was 54.07.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Coloplast AS E10 Related Terms

Thank you for viewing the detailed overview of Coloplast AS's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines